(Q42242801)

English

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.

scientific article published on 26 October 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Daisuke Hasegawa

object named as

Daisuke Hasegawa

5

0 references

object named as

Motohiro Kato

1

0 references

3

object named as

Atsushi Manabe

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Katsuyoshi Koh

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tomohiro Saito

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Keiichi Isoyama

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Akitoshi Kinoshita

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Miho Maeda

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yuri Okimoto

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Michiko Kajiwara

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Takashi Kaneko

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Kanji Sugita

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Akira Kikuchi

13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Masahiro Tsuchida

14

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Akira Ohara

15

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

26 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

164

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

376-383

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Treating childhood acute lymphoblastic leukemia without cranial irradiation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12632

21 January 2018

Identifiers

10.1111/BJH.12632

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42242801&oldid=1823449676"